Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_3
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (28.6%)
N/A5 (71.4%)

Trials by Status

terminated113%
completed788%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8